EMBC

Embecta Corp. is a global medical device company focused on diabetes care solutions. The company manufactures and distributes insulin delivery devices, including pen needles and syringes, serving millions of people with diabetes worldwide. Embecta was spun off from Becton, Dickinson and Company in 2022 to operate as an independent diabetes care specialist. The company maintains manufacturing facilities and distribution networks across North America, Europe, and Asia-Pacific, generating revenue through sales to pharmacies, distributors, and healthcare institutions.